ArticleMaterials today. Bio2026
Thermoreversible cell-derived extracellular matrix only hydrogel (CEOgel): Development, characterization, and applications.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The application of growth factors in bone tissue engineering delivery systems and collaborative innovation strategies.Annals of medicine · 2026Review
- Advances in cell-derived extracellular matrix for 3D tumor modelling.Materials today. Bio · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Decellularized extracellular matrix (dECM) has been widely used as a biomimetic material for three-dimensional cell culture and tissue regeneration. Although tissue-derived ECM is the conventional source of dECM, cell-derived ECM (cECM) has emerged as an attractive alternative. Various cECM-based formulations such as powders, films, and preformed gels have been reported, but thermosensitive cECM hydrogels remain largely unexplored. Here, we report a novel method to produce a thermoreversible hydrogel exclusively made from cECM, termed CEOgel. Once
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.